DOTZ NANO LIMITED — Investor Presentation 2021

Jul 25, 2021

==> picture [412 x 151] intentionally omitted <==

Company Presentation

Disclaimer

• This presentation has been prepared by Dotz Nano Limited ( Dotz) . It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Dotz. You should not treat the contents of this presentation, or any information provided in connection with it, as financial product advice or advice relating to legal, taxation or investment matters.

• This presentation and the information contained herein and all electronic and/or hard copy documentation which comprise it are being provided to you solely for your information and may not be copied, reproduced, distributed, disclosed or published, in whole or in part, to any other person for any purpose whatsoever at any time without the prior written consent of Dotz. This presentation is not an offer to any person nor is it a prospectus.

• Dotz has prepared this document based on information available to it at the time of preparation. No representation or warranty (whether express or implied) is made by the Dotz or any of their officers, advisers, agents or employees as to the accuracy, completeness or reasonableness of the information, statements, opinions or matters (express or implied) arising out of, contained in or derived from this presentation or provided in connection with it, or any omission from this presentation, nor as to the attainability of any estimates, forecast or projections set out in this presentation.

• This presentation is not investment or financial product advice (nor tax, accounting or legal advice) and is not intended to be used for the basis of making an investment decision. The information contained in this presentation has been prepared without taking into account the objectives, financial situation or needs of individuals.

• This presentation is provided expressly on the basis that you will carry out your own independent inquiries into the matters contained in the presentation and make your own independent decisions about the affairs, financial position or prospects of Dotz. Dotz reserve the right to update, amend or supplement the information at any time in their absolute discretion (without incurring any obligation to do so).

• Neither Dotz, nor their related bodies corporate, officers, their advisers, agents and employees accept any responsibility or liability to you or to any other person or entity arising out of this presentation including pursuant to the general law (whether for negligence, under statute or otherwise), or under the Australian Securities and Investments Commission Act 2001, Corporations Act 2001, competition and any such responsibility or liability is, to the maximum extent permitted by law, expressly disclaimed and excluded.

• This presentation may contain forward looking statements. Forward looking statements include, but are not limited to, statements concerning Dotz’s business, future prospects and other statements that are not historical facts. Although Dotz believes that its expectations reflected in these forward-looking statements are reasonable as at the date of this presentation, such statements involve risks and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements. Dotz has no intention to update or revise forward-looking statements, regardless of whether new information, future events or any other factors affect the information contained in this presentation, except where required by law.

• Nothing in this material should be construed as either an offer to sell or a solicitation of an offer to buy or sell securities. It does not include all available information and should not be used in isolation as a basis to invest in Dotz.

2

Technology. What are Quantum dots?

Graphene Quantum Dots (GQDs) is a new advanced material made from carbon sources and are nontoxic . Dotz developed 50 different families

GQDs are an advanced multifunctional material with applications in bioimaging, in product, Biotech, LEDs lighter converters, solar cells, sensors and more

One of the most prominent features of GQDs is that the absorb photons of light, then re-emit photons at a different wavelength. For example, when exposed to UV light, GQDs fluoresce

The fluorescence color can be tuned by changing the size or doping of the particle and will have a unique digital signature

==> picture [119 x 45] intentionally omitted <==

The challenge. Product protection and Brand authentication

==> picture [920 x 170] intentionally omitted <==

----- Start of picture text -----

Premium
Industrial Industrial Safety and Pharma-
Alcohol consumer Tobacco
fluids products health ceuticals
products
----- End of picture text -----

$2.8 TRILLION PRODUCTS ARE COUNTERFEITED

• Regulations becoming stricter

• Validating product ownership becomes common

• Covid19 will cause a wave of fake goods including medical essentials

==> picture [119 x 45] intentionally omitted <==

What we do

Disrupting the anti-counterfeiting and tracing industry by providing a game-changing end-to-end security and tracing solution, that is:

• Marking the bulk substance with no impact to properties

• Economical

• Eco-friendly

• Accompanied by on-site detectors

• Extensive markers portfolio

• Withstand harsh conditions

• Impossible to reverse-engineer

==> picture [610 x 555] intentionally omitted <==

----- Start of picture text -----

MEDICAL EQUIPMENT BIO IMAGING
OIL & GAS TRACES
IN-PLANT TAGGING
SPORT
EQUIPMENT ENGINEERED
PLASTICS
MARKING LUBRICANTS ARGO-CHEMICALS 5
----- End of picture text -----

5

Our Unique Technology

• Impossible to Reverse engineer

• Smartphone detection

• Anti-counterfeiting, Tracers, Bio Imaging

• No royalties (fully owned patents)

• Multiple layers - 3 security levels with one product:

• Covert, Semi-forensic Forensic

• Fluorescent marking fully adapted by market

• Overall solution. Large companies (forensic for product liability), small distributing centers (semiforensic), to end user back home (utilizing a 1$ LED light)

==> picture [279 x 241] intentionally omitted <==

==> picture [92 x 168] intentionally omitted <==

==> picture [305 x 168] intentionally omitted <==

==> picture [180 x 98] intentionally omitted <==

==> picture [66 x 119] intentionally omitted <==

6

==> picture [93 x 215] intentionally omitted <==

RT-LAMP

Current “Golden-Standard” vs. Dotz™Diagnostics

Isothermal Results Saliva/Swab Heating for 17min Incubation Negative Positive

==> picture [817 x 191] intentionally omitted <==

==> picture [36 x 162] intentionally omitted <==

PCR

c

Dotz Diagnostics Solution- latest .

Key points:

The US$2.1m purchase order is for the supply of Dotz’s nasopharyngeal swab and saliva-based Test Kits for the next six months for use in the UAE, Egypt and Sudan.

The Dotz Test Kits will be shipped monthly with 50% of each monthly shipment paid upfront and the remainder on delivery.

The distribution agreement grants Hygiene Links the exclusive right to sell the Dotz Test Kits in the UAE, Eqypt and Sudan for an initial two year term, subject to minimum purchase orders being met. Dotz has entered into a non-exclusive manufacturing agreement with USA-based Systaaq Diagnostic Products to manufacture its nasopharyngeal swab and saliva-based Test Kits.

Dotz has obtained CE Mark authorisation for its nasopharyngeal swab and saliva-based Test Kits and is currently awaiting US FDA Emergency Use Authorisation approval.

==> picture [119 x 45] intentionally omitted <==

Active V-SRD with Dotz Inside- Latest

Key points

In April, Dotz signed five-year supply and distribution agreements for a verifiable surface sanitisation solution with Zohar Dalia Professional Ltd, a subsidiary of Zohar Dalia Cooperative Agricultural Association Ltd - Israel’s largest manufacturer supplier of detergent intermediates and cleaning products.

Zohar Dalia’s Active V-SRD product was tested in experimental conditions that reflected as much as possible real conditions over the following key time periods: after 24 hours, 48 hours and 72 hours.

Under the exclusive supply agreement, Dotz will supply its non-toxic molecular markers and detectors for use with Zohar Dalia’s slow-release disinfectant, exclusively licensed from the Israel Ministry of Defense.

The non-exclusive distribution agreement enables Dotz to promote and sell the Active V-SRD product in multiple approved markets, including the UK, India, Italy, France, Australia, Germany, Spain and throughout Africa.

The agreements follow a successful pilot where Dotz marked 1,000 litres of Zohar Dalia’s disinfectant with its security taggants to verify proper surface sanitisation within Tel Avi Ben Gurion Airport as well as other public places.

==> picture [91 x 77] intentionally omitted <==

Long-lasting protection

==> picture [107 x 88] intentionally omitted <==

Verifiable protection

==> picture [78 x 63] intentionally omitted <==

==> picture [119 x 45] intentionally omitted <==

Cost - effective protection

==> picture [256 x 94] intentionally omitted <==

Thank you.